Please verify your email address to receive email notifications.

Enter your email address

We have sent you a verification email. Please check your inbox and spam folder.

Unable to send verification, please refresh and try again later.

  • Q&A with Australian Health Practitioners

    The Thin Prep Test is most effective in detecting cervical changes, why is it not funded by medicare?

  • Find a professional to answer your question

  • ACCF’s Vision is to protect and enhance women’s health by eliminating cervical cancer and enabling treatment for women with cervical cancer and related health issues, … View Profile

    Thank you for your question. The Australian Government reviewed the ThinPrep technology - liquid based cytology (LBC) - in 2009 where it found LBC to be safe and at least as effective as the conventional Pap test when the slides are reviewed manually by laboratory staff, and it found the ThinPrep Pap test to be more effective when the slides are read by the ThinPrep Imaging System (an automated system that pinpoints any suspicious areas on the slide). However, the technology was not found to be cost effective based on the existing 2 yearly screening interval. A renewal of the National Cervical Screening Program is currently underway, involving a comprehensive review of science and technologies based on the best available evidence and clinical practice. This is likely to result in a change to our cervical screening program. An announcement on the renewal decision is expected in the coming months or earlier.

answer this question

You must be a Health Professional to answer this question. Log in or Sign up .

You may also like these related questions

Empowering Australians to make better health choices